{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T01:41:32Z","timestamp":1791250892988,"version":"4.1.0"},"reference-count":26,"publisher":"Scientific Scholar","issue":"3","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,7]]},"abstract":"<jats:sec>\n                    <jats:title>Purpose:<\/jats:title>\n                    <jats:p>Adrenocortical carcinoma (ACC) is a rare primary malignancy of the adrenal gland. The present study was aimed to compare the performance of fluoro-2-deoxyglucose-positron emission tomography\u2013computed tomography (FDG-PET-CT) compared to contrast-enhanced computed tomography (CECT) in diagnosis and management of ACC.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and Methods:<\/jats:title>\n                    <jats:p>A retrospective analysis of the PET-CT studies from January 2010 to October 2020 was performed. Patients with adrenal lesions suspicious of ACC and diagnosed cases of ACC who underwent PET-CT for staging, restaging, and surveillance were reanalyzed. The PET-CT parameters were compared with the clinical, biochemical, histopathological, and CECT parameters.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>The study included 96 scans performed in 77 patients (36 males, aged 40.4 \u00b1 17.9 years). Of these, 55 scans were performed to diagnose and stage suspected ACC (30 of them diagnosed as ACC), 31 for restaging, and 10 scans for surveillance of ACC. PET\/CT revealed metastases from an extra-adrenal primary in 5\/55 patients. FDG-PET-CT had a sensitivity and specificity of 100% and 70% to diagnose ACC. Standardized uptake value-peak more than 5.4 had a sensitivity of 90.9% and specificity of 91.7% for differentiating ACC from non-ACC lesions, while tumor-to-liver ratio peak (TLRpeak) of 3.3 was most specific. PET-CT changed the staging in 23.3% of the patients with an accuracy of 100%. PET-CT changed the management plan in 25.8% of the patients during restaging with a sensitivity and specificity of 95.6% and 100%, respectively. For surveillance, CECT was as sensitive as PET-CT; however, PET-CT was more specific (100% vs. 97.9%).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>FDG-PET-CT performs better than CECT in the diagnosis, staging, restaging, and surveillance of ACC.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/ijnm.ijnm_4_22","type":"journal-article","created":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T09:43:41Z","timestamp":1667295821000},"page":"227-235","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":5,"title":["Fluoro-2-Deoxyglucose-Positron Emission Tomography\/Computed Tomography in the Diagnosis and Management of Adrenocortical Carcinoma"],"prefix":"10.25259","volume":"37","author":[{"given":"Venkata Subramanian","family":"Krishnaraju","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajender","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karthikeyan","family":"Subramanian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhagwant Rai","family":"Mittal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harmandeep","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debajyoti","family":"Chatterjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rama","family":"Walia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10894","reference":[{"key":"R1-3-20240902","first-page":"102","article-title":"Distinguishing benign from malignant adrenal masses","volume":"3","author":"Francis","year":"2003","journal-title":"Cancer Imaging"},{"key":"R2-3-20240902","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1210\/jc.2005-2639","article-title":"Clinical review: Adrenocortical carcinoma: clinical update","volume":"91","author":"Allolio","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"R3-3-20240902","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S0022-5347(05)64023-2","article-title":"Adrenocortical carcinoma: Diagnosis, evaluation and treatment","volume":"169","author":"Ng","year":"2003","journal-title":"J Urol"},{"key":"R4-3-20240902","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1002\/(SICI)1097-0142(20000215)88:4<711::AID-CNCR1>3.0.CO;2-W","article-title":"Adrenocortical carcinoma: Clinical and laboratory observations","volume":"88","author":"Wajchenberg","year":"2000","journal-title":"Cancer"},{"key":"R5-3-20240902","doi-asserted-by":"crossref","first-page":"636","DOI":"10.14740\/jocmr3503w","article-title":"The characteristics and trends in adrenocortical carcinoma: A United States population based study","volume":"10","author":"Sharma","year":"2018","journal-title":"J Clin Med Res"},{"key":"R6-3-20240902","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13244-019-0688-8","article-title":"Imaging features of adrenal masses","volume":"10","author":"Albano","year":"2019","journal-title":"Insights Imaging"},{"key":"R7-3-20240902","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1210\/jc.2005-1540","article-title":"Diagnostic and prognostic value of 18-fluorodeoxyglucose positron emission tomography in adrenocortical carcinoma: a prospective comparison with computed tomography","volume":"91","author":"Leboulleux","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"R8-3-20240902","first-page":"32","article-title":"18F-FDG PET\/CT in the evaluation of adrenal masses","volume":"47","author":"Metser","year":"2006","journal-title":"J Nucl Med"},{"key":"R9-3-20240902","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1210\/jc.2005-2612","article-title":"Use of [18F] fluorodeoxyglucose positron emission tomography in evaluating locally recurrent and metastatic adrenocortical carcinoma","volume":"91","author":"Mackie","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"R10-3-20240902","doi-asserted-by":"crossref","first-page":"e368","DOI":"10.1097\/RLU.0000000000001112","article-title":"Molecular imaging in the management of adrenocortical cancer: A systematic review","volume":"41","author":"Wong","year":"2016","journal-title":"Clin Nucl Med"},{"key":"R11-3-20240902","doi-asserted-by":"crossref","first-page":"61","DOI":"10.2214\/ajr.144.1.61","article-title":"Differentiation of malignant from benign adrenal masses: Predictive indices on computed tomography","volume":"144","author":"Hussain","year":"1985","journal-title":"AJR Am J Roentgenol"},{"key":"R12-3-20240902","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/j.jacr.2017.05.001","article-title":"Management of incidental adrenal masses: A white paper of the ACR incidental findings committee","volume":"14","author":"Mayo-Smith","year":"2017","journal-title":"J Am Coll Radiol"},{"key":"R13-3-20240902","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1530\/eje.0.1430111","article-title":"Outcome in patients with adrenal incidentaloma selected for surgery: An analysis of 88 cases investigated in a single clinical center","volume":"143","author":"Luton","year":"2000","journal-title":"Eur J Endocrinol"},{"key":"R14-3-20240902","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1148\/radiol.2223010766","article-title":"Adrenal masses: Characterization with combined unenhanced and delayed enhanced CT","volume":"222","author":"Caoili","year":"2002","journal-title":"Radiology"},{"key":"R15-3-20240902","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1097\/RLU.0b013e318162ddb3","article-title":"Increased FDG uptake in bilateral adrenal tuberculosis appearing like malignancy","volume":"33","author":"Li","year":"2008","journal-title":"Clin Nucl Med"},{"key":"R16-3-20240902","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1097\/RLU.0b013e3181813179","article-title":"Increased F-18 FDG uptake in resolving atraumatic bilateral adrenal hemorrhage (hematoma) on PET\/CT","volume":"33","author":"Repko","year":"2008","journal-title":"Clin Nucl Med"},{"key":"R17-3-20240902","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.2214\/ajr.168.5.9129444","article-title":"Evaluation of adrenal masses in patients with bronchogenic carcinoma using 18F-fluorodeoxyglucose positron emission tomography","volume":"168","author":"Erasmus","year":"1997","journal-title":"AJR Am J Roentgenol"},{"key":"R18-3-20240902","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1148\/radiol.11100569","article-title":"Characterization of adrenal masses by using FDG PET: A systematic review and meta-analysis of diagnostic test performance","volume":"259","author":"Boland","year":"2011","journal-title":"Radiology"},{"key":"R19-3-20240902","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1007\/s12672-011-0091-5","article-title":"FDG PET in the management of patients with adrenal masses and adrenocortical carcinoma","volume":"2","author":"Deandreis","year":"2011","journal-title":"Horm Cancer"},{"key":"R20-3-20240902","doi-asserted-by":"crossref","first-page":"956","DOI":"10.2214\/AJR.08.1431","article-title":"PET\/CT for the characterization of adrenal masses in patients with cancer: qualitative versus quantitative accuracy in 150 consecutive patients","volume":"192","author":"Boland","year":"2009","journal-title":"AJR Am J Roentgenol"},{"key":"R21-3-20240902","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1148\/radiol.2383042164","article-title":"Adrenal lesions: Characterization with fused PET\/CT image in patients with proved or suspected malignancy \u2013 Initial experience","volume":"238","author":"Blake","year":"2006","journal-title":"Radiology"},{"key":"R22-3-20240902","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1210\/jc.2008-2302","article-title":"18F-Fluorodeoxyglucose positron emission tomography for the diagnosis of adrenocortical tumors: A prospective study in 77 operated patients","volume":"94","author":"Groussin","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"R23-3-20240902","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1148\/rg.343130127","article-title":"From the radiologic pathology archives: Adrenal tumors and tumor-like conditions in the adult: radiologic-pathologic correlation","volume":"34","author":"Lattin","year":"2014","journal-title":"Radiographics"},{"key":"R24-3-20240902","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s00268-012-1802-y","article-title":"(18) F-FDG uptake at initial staging of the adrenocortical cancers: A diagnostic tool but not of prognostic value","volume":"37","author":"Tessonnier","year":"2013","journal-title":"World J Surg"},{"key":"R25-3-20240902","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/cncr.24030","article-title":"Limited prognostic value of the 2004 International Union Against Cancer staging classification for adrenocortical carcinoma: Proposal for a Revised TNM Classification","volume":"115","author":"Fassnacht","year":"2009","journal-title":"Cancer"},{"key":"R26-3-20240902","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1007\/s00259-014-2834-3","article-title":"Impact of 18F-FDG PET\/CT on the management of adrenocortical carcinoma: Analysis of 106 patients","volume":"41","author":"Takeuchi","year":"2014","journal-title":"Eur J Nucl Med Mol Imaging"}],"container-title":["Indian Journal of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.4103\/ijnm.ijnm_4_22","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T07:37:17Z","timestamp":1779694637000},"score":1,"resource":{"primary":{"URL":"https:\/\/ijnm.co.in\/fluoro-2-deoxyglucose-positron-emission-tomography-computed-tomography-in-the-diagnosis-and-management-of-adrenocortical-carcinoma-a-10-year-experience-from-a-tertiary-care-institute\/"}},"subtitle":["A 10-Year Experience from a Tertiary Care Institute"],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":26,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.4103\/ijnm.ijnm_4_22","relation":{},"ISSN":["0972-3919"],"issn-type":[{"value":"0972-3919","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7]]}}}